Search Results - Allyon, J

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    POD-11.01: Dose Finding and Safety Analysis of Inecalcitol in Combination with Docetaxel-Prednisone Regimen in Hormone-Refractory Prostate Cancer (HRPC) Patients (PTS)

    POD-11.01: Dose Finding and Safety Analysis of Inecalcitol in Combination with Docetaxel-Prednisone Regimen in Hormone-Refractory Prostate Cancer (HRPC) Patients (PTS) by Medioni, J, Deplanque, G, Maurina, T, Ferrero, J, Rodier, J, Raymond, E, Allyon, J, Kalla, S, Dufour-Lamartinie, J, Oudard, S

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    7030 Dose finding and safety analysis of inecalcitol in combination with docetaxel-prednisone regimen in hormone-refractory prostate cancer (HRPC) patients (pts)

    7030 Dose finding and safety analysis of inecalcitol in combination with docetaxel-prednisone regimen in hormone-refractory prostate cancer (HRPC) patients (pts) by Medioni, J, Deplanque, G, Maurina, T, Ferrero, J.M, Rodier, J.M, Raymond, E, Allyon, J, Kalla, S, Dufour-Lamartinie, J.F, Oudard, S

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    430 Dose finding of inecalcitol, a new VDR agonist, in combination with docetaxel–prednisone regimen for castrate-resistant prostate cancer (HRPC) patients (pts)

    430 Dose finding of inecalcitol, a new VDR agonist, in combination with docetaxel–prednisone regimen for castrate-resistant prostate cancer (HRPC) patients (pts) by Medioni, J, Deplanque, G, Ferrero, J.M, Maurina, T, Rodier, J.M, Raymond, E, Allyon, G, Renaux, S, Dufour-Lamartinie, J.F, Oudard, S

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: